1 - 25 of 37 results for author:"Becker I." in Literature citations
Results Customize
› Repeat search in UniProtKB (3,593)
| Disease severity in patients infected with Leishmania mexicana relates to IL-1beta. Fernandez-Figueroa E.A., Rangel-Escareno C., Espinosa-Mateos V., Carrillo-Sanchez K., Salaiza-Suazo N., Carrada-Figueroa G., March-Mifsut S., Becker I. PLoS Negl Trop Dis 6:e1533-e1533(2012) · Mapped (3) |
| alpha-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease. Lastres-Becker I., Ulusoy A., Innamorato N.G., Sahin G., Rabano A., Kirik D., Cuadrado A. Hum. Mol. Genet. 21:3173-3192(2012) · Mapped (16) |
| Connexin 36 is expressed in beta and connexins 26 and 32 in acinar cells at the end of the secondary transition of mouse pancreatic development and increase during fetal and perinatal life. Perez-Armendariz E.M., Cruz-Miguel L., Coronel-Cruz C., Esparza-Aguilar M., Pinzon-Estrada E., Rancano-Camacho E., Zacarias-Climaco G., Olivares P.F., Espinosa A.M., Becker I. et al. Anat Rec (Hoboken) 295:980-990(2012) · Mapped (15) |
| Drug target validation of the trypanothione pathway enzymes through metabolic modelling. Olin-Sandoval V., Gonzalez-Chavez Z., Berzunza-Cruz M., Martinez I., Jasso-Chavez R., Becker I., Espinoza B., Moreno-Sanchez R., Saavedra E. FEBS J. 279:1811-1833(2012) · UniProtKB (2) |
| Proper synaptic vesicle formation and neuronal network activity critically rely on syndapin I. Koch D., Spiwoks-Becker I., Sabanov V., Sinning A., Dugladze T., Stellmacher A., Ahuja R., Grimm J., Schuler S., Muller A. et al. |
| Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum. Granado N., Lastres-Becker I., Ares-Santos S., Oliva I., Martin E., Cuadrado A., Moratalla R. Glia 59:1850-1863(2011) · Mapped (4) |
| N-acetylaspartylglutamate synthetase II synthesizes N-acetylaspartylglutamylglutamate. Lodder-Gadaczek J., Becker I., Gieselmann V., Wang-Eckhardt L., Eckhardt M. J. Biol. Chem. 286:16693-16706(2011) · Mapped (3) |
| Molecular characterization of N-acetylaspartylglutamate synthetase. Becker I., Lodder J., Gieselmann V., Eckhardt M. J. Biol. Chem. 285:29156-29164(2010) · UniProtKB (2) |
| A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice. Kurz A., Double K.L., Lastres-Becker I., Tozzi A., Tantucci M., Bockhart V., Bonin M., Garcia-Arencibia M., Nuber S., Schlaudraff F. et al. PLoS ONE 5:e11464-e11464(2010) · Mapped (1) |
| Leishmania mexicana lipophosphoglycan differentially regulates PKCalpha-induced oxidative burst in macrophages of BALB/c and C57BL/6 mice. Delgado-Dominguez J., Gonzalez-Aguilar H., Aguirre-Garcia M., Gutierrez-Kobeh L., Berzunza-Cruz M., Ruiz-Remigio A., Robles-Flores M., Becker I. Parasite Immunol. 32:440-449(2010) · Mapped (4) |
| Evidence for the involvement of genetic variation in the oxytocin receptor gene (OXTR) in the etiology of autistic disorders on high-functioning level. Wermter A.K., Kamp-Becker I., Hesse P., Schulte-Korne G., Strauch K., Remschmidt H. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B:629-639(2010) · Mapped (2) |
| Expression and function of the coxsackie and adenovirus receptor in Barrett's esophagus and associated neoplasia. Anders M., Rosch T., Kuster K., Becker I., Hofler H., Stein H.J., Meining A., Wiedenmann B., Sarbia M. Cancer Gene Ther. 16:508-515(2009) · Mapped (3) |
| Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease. Sagredo O., Gonzalez S., Aroyo I., Pazos M.R., Benito C., Lastres-Becker I., Romero J.P., Tolon R.M., Mechoulam R., Brouillet E. et al. Glia 57:1154-1167(2009) · Mapped (3) |
| Pituitary adenylate cyclase-activating polypeptide stimulates glial fibrillary acidic protein gene expression in cortical precursor cells by activating Ras and Rap1. Lastres-Becker I., Fernandez-Perez A., Cebolla B., Vallejo M. Mol. Cell. Neurosci. 39:291-301(2008) · Mapped (3) |
| Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice. Lastres-Becker I., Brodesser S., Lutjohann D., Azizov M., Buchmann J., Hintermann E., Sandhoff K., Schurmann A., Nowock J., Auburger G. Hum. Mol. Genet. 17:1465-1481(2008) · Mapped (18) |
| No evidence for involvement of genetic variants in the X-linked neuroligin genes NLGN3 and NLGN4X in probands with autism spectrum disorder on high functioning level. Wermter A.K., Kamp-Becker I., Strauch K., Schulte-Korne G., Remschmidt H. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B:535-537(2008) · Mapped (11) |
| Perturbation of the dimer interface of triosephosphate isomerase and its effect on Trypanosoma cruzi. Olivares-Illana V., Rodriguez-Romero A., Becker I., Berzunza M., Garcia J., Perez-Montfort R., Cabrera N., Lopez-Calahorra F., de Gomez-Puyou M.T., Gomez-Puyou A. PLoS Negl Trop Dis 1:e1-e1(2007) · Mapped (1) |
| Transcriptome comparison of murine wild-type and synaptophysin-deficient retina reveals complete identity. Bai L., Spiwoks-Becker I., Leube R.E. Brain Res. 1081:53-58(2006) · Mapped (3) |
| The innate immune response to Entamoeba histolytica lipopeptidophosphoglycan is mediated by toll-like receptors 2 and 4. Maldonado-Bernal C., Kirschning C.J., Rosenstein Y., Rocha L.M., Rios-Sarabia N., Espinosa-Cantellano M., Becker I., Estrada I., Salazar-Gonzalez R.M., Lopez-Macias C. et al. Parasite Immunol. 27:127-137(2005) · Mapped (6) |
| Cannabinoid CB(1) receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice. Gonzalez S., Mena M.A., Lastres-Becker I., Serrano A., de Yebenes J.G., Ramos J.A., Fernandez-Ruiz J. Brain Res. 1046:195-206(2005) · Mapped (9) |
| The genome of Desulfotalea psychrophila, a sulfate-reducing bacterium from permanently cold Arctic sediments. Rabus R., Ruepp A., Frickey T., Rattei T., Fartmann B., Stark M., Bauer M., Zibat A., Lombardot T., Becker I. et al. Environ. Microbiol. 6:887-902(2004) · UniProtKB (3,233) |
| Neoexpression of N-cadherin in E-cadherin positive colon cancers. Rosivatz E., Becker I., Bamba M., Schott C., Diebold J., Mayr D., Hofler H., Becker K.F. Int. J. Cancer 111:711-719(2004) · Mapped (2) |
| Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Becker I., Salaiza N., Aguirre M., Delgado J., Carrillo-Carrasco N., Kobeh L.G., Ruiz A., Cervantes R., Torres A.P., Cabrera N. et al. Mol. Biochem. Parasitol. 130:65-74(2003) · Mapped (2) |
| The CD43 coreceptor molecule recruits the zeta-chain as part of its signaling pathway. Cruz-Munoz M.E., Salas-Vidal E., Salaiza-Suazo N., Becker I., Pedraza-Alva G., Rosenstein Y. J. Immunol. 171:1901-1908(2003) · Mapped (7) |
| Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16. Varsani A., Williamson A.L., de Villiers D., Becker I., Christensen N.D., Rybicki E.P. J. Virol. 77:8386-8393(2003) · UniProtKB (1) |